Detailed answers about MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE, including incorporation, status, business activity, and accounts information.
When was MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE founded?
MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE was officially incorporated on 21 January 2019 and is registered under company number 11777857. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE?
MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE do?
MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE operates in the following sectors: 58141 - Publishing of learned journals, 68202 - Letting and operating of conference and exhibition centres, 85520 - Cultural education. These SIC codes provide insight into the company's business activities and industry focus.
What is MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE's registered address?
The registered office address of MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE is UNIT 3, OFFICE A, 1ST FLOOR, 6-7 ST. MARY AT HILL, LONDON, ENGLAND, EC3R 8EE. This is the official address filed with Companies House for legal and statutory correspondence.
Is MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE financially stable?
The most recent accounts for MIDDLE EAST & NORTH AFRICA HEMATOLOGY LEAGUE were made up to 31 January 2025, filed as DORMANT. Next accounts are due by 31 October 2026.